Abstract: An actuator unit includes a base actuator and an additional actuator, via which a useful circuit can be opened and closed. Given proper functioning, the base actuator can be activated by supplying electric energy and deactivated by not supplying electric energy. The additional actuator can be deactivated by supplying electric energy and can be activated via manual operation. A control unit deactivates the additional actuator only when an actual activation state of the base actuator differs from a desired activation state of the base actuator.

Abstract: Data transfer between a secure computer and a number of input/output units occurs via a bus control unit connected to the secure computer and a serial bus system. The bus control unit cyclically activates the input/output units connected to the bus system and transfers multi-bit message to the respective activated input/output unit. In order to produce a data transfer method which enables security/related signals to be transmitted via a non-error-protected bus system, at least one of the input/output units is designed as a security unit. Further, the multi-bit message transferred to the security unit has at least one checkbit. The security unit interprets the transferred multi-bit message as correct only if the checkbit alternates within a predefined monitoring period.

Abstract: Substituted propanolamine derivatives, their pharmaceutically tolerated salts and physiologically functional derivatives thereof are described. Also described are compounds of formula I in which the radicals have the abovementioned meanings, and their physiologically tolerated salts, physiologically functional derivates and processes for their preparation. The compounds are suitable as, for example, hypolipidemics.

Abstract: An arrangement includes two series-connected switching contacts in two contactors. The tripping signal thereof is generated with a variable time offset so that the number of disconnection processes and connection processes, which are carried out first in time, are virtually the same during lengthy use.

Abstract: The invention relates to the compound of the formula 1 and to its physiologically acceptable salts. The compound is suitable, for example, as a hypolipidemic.

Abstract: Novel aromatic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof. The invention relates to substituted aromatic fluoroglycoside derivatives of the formula I in which the radicals have the stated meanings, and their physiologically tolerated salts and process for their preparation. The compounds are suitable for example as antidiabetics.

Abstract: Novel heterocyclic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof.

Abstract: The invention relates to a vertebrate intestinal protein which absorbs cholesterol. It was possible to identify the protein by means of high-affinity crosslinking compounds. The invention further relates to this use of the protein for carrying out a method for identifying a compound which inhibits cholesterol absorption in the intestine.

Abstract: Novel thiophene glycoside derivatives of the formula I 1

Abstract: The invention describes a method for isolating an intestinal protein which is able to bind cholesterol and/or cholesterol uptake inhibitors. Methods of identifying inhibitors of cholesterol uptake and related pharmaceuticals and methods of treatment also are described.

Abstract: Use of inhibitors of cellular Na+/H+ exchanger (NHE) for the production of a medicament for the normalization of serum lipids

Abstract: The present invention is directed to a 1,4-benzothiepine 1,1-dioxide compound of formula I 1

Abstract: One embodiment of the invention relates to compounds of the formula I, 1

Abstract: One embodiment of the invention relates to compounds of the formula I, 1

Abstract: One embodiment of the invention relates to compounds of the formula I: 1

Abstract: Compounds of the formula I, for example, are disclosed, in which R1, R2, R3, R4, R5, and R6 independently of one another are (C0-C30)-alkylene-L or are the meanings given in the description, and where L is shown connected to (C0-C30)-alkylene as follows: where Rx, Ry, Rz have the meanings given in the description, and their physiologically acceptable salts. The compounds are suitable for use, for example, as hypolipidemics.

Abstract: Substituted propanolamine derivatives, their pharmaceutically tolerated salts and physiologically functional derivatives thereof are described.

Abstract: The present invention is directed to an aryl-substituted propanolamine derivative of formula I 1

Abstract: The present invention is directed to a 1,4-benzothiepine 1,1-dioxide compound of formula I 1

Abstract: Substituted 1,3-diaryl-2-pyridin-2-yl-3-(pyridin-2-ylamino)propanol derivatives of the formula (I), and salts thereof, in which the radicals have the meanings given in the specification, and physiologically tolerated salts thereof and processes for their preparation are described. The compounds are suitable, for example, as hypolipidemic agents.